ClinVar Miner

Submissions for variant NM_000057.4(BLM):c.2915G>T (p.Gly972Val)

gnomAD frequency: 0.00001  dbSNP: rs150475674
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000820182 SCV000960883 uncertain significance Bloom syndrome 2022-11-01 criteria provided, single submitter clinical testing This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 972 of the BLM protein (p.Gly972Val). This variant is present in population databases (rs150475674, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with BLM-related conditions. ClinVar contains an entry for this variant (Variation ID: 662521). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BLM protein function. Experimental studies have shown that this missense change affects BLM function (PMID: 23129629, 26788541). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV001016923 SCV001177930 uncertain significance Hereditary cancer-predisposing syndrome 2023-02-23 criteria provided, single submitter clinical testing The p.G972V variant (also known as c.2915G>T), located in coding exon 14 of the BLM gene, results from a G to T substitution at nucleotide position 2915. The glycine at codon 972 is replaced by valine, an amino acid with dissimilar properties. Functional studies performed in yeast showed increased sensitivity to DNA damaging agents comparable to that of known BLM mutations (Mirzaei H et al. Proc. Natl. Acad. Sci. U.S.A. 2012 Nov;109:19357-62; Shastri VM et al. Mol Genet Genomic Med. 2016 Jan;4:106-19). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Natera, Inc. RCV000820182 SCV001454867 uncertain significance Bloom syndrome 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.